申请人:SYNTEX (U.S.A.) INC.
公开号:EP0457243A1
公开(公告)日:1991-11-21
Compounds of Formula I:
in which
Z is an oxo group or two hydrogens;
X and Y are independently selected from hydrogen, halogen, hydroxy, lower alkoxy, benzyloxy, lower alkyl, lower cycloalkyl, nitro, amino, amino-carbonyl, (lower alkyl)amino, di(lower alkyl)amino and (lower alkanoyl)amino;
R¹ is selected from
in which
p is 0 or 1;
n is 1, 2 or 3; and
R² is hydrogen, lower alkyl, C₃₋₈ cycloalkyl, C₃₋₈ cycloalkyl-C₁₋₂ alkyl, or a group (CH₂)tR³ where t is 1 or 2 and R³ is thienyl, pyrrolyl or furyl optionally further substituted by one or two substituents selected from lower alkyl, lower alkoxy, trifluoromethyl or halogen, or is phenyl optionally substituted by one or two substituents selected from C₁₋₄ alkoxy, trifluoromethyl, halogen, nitro, carboxy, esterified carboxy, and C₁₋₄ alkyl optionally substituted by hydroxy, C₁₋₄ alkoxy, carboxy, esterified carboxy or in vivo hydrolyzable acyloxy; or their pharmaceutically acceptable salts, or an individual isomer or mixture of isomers thereof, the processes for the preparation thereof, as well as compositions containing them and their methods of use.
式 I 的化合物:
其中
Z 是一个氧代基团或两个氢;
X 和 Y 独立选自氢、卤素、羟基、低级烷氧基、苄氧基、低级烷基、低级环烷基、硝基、氨基、氨基羰基、(低级烷基)氨基、二(低级烷基)氨基和(低级烷酰基)氨基;
R¹ 选自
其中
p 是 0 或 1
n 是 1、2 或 3;以及
R² 是氢、低级烷基、C₃₋₈环烷基、C₃₋₈环烷基-C₁₋₂烷基或基团 (CH₂)tR³ 其中 t 是 1 或 2,R³ 是噻吩基、是噻吩基、吡咯基或呋喃基,可任选地被选自低级烷基、低级烷氧基、三氟甲基或卤素的一个或两个取代基进一步取代、或苯基,可任选被一个或两个选自 C₁₋₄烷氧基、三氟甲基、卤素、硝基、羧基、酯化羧基和 C₁₋₄烷氧基的取代基取代、C₁₋₄ 烷氧基、卤素、硝基、羧基、酯化羧基和 C₁₋₄ 烷基中任选被羟基、C₁₋₄ 烷氧基、羧基、酯化羧基或体内可水解的酰氧基取代;或它们的药学上可接受的盐,或它们的单个异构体或异构体混合物,它们的制备工艺,以及含有它们的组合物和它们的使用方法。